bioRxiv · 10.64898/2025.12.27.696684
Comprehensive Mapping of the Virus and Host Factors that Guide the Paths of HIV-1 Escape from a Therapeutic
Abstract
HIV-1 resistance to therapeutics can emerge through diverse mutational routes, yet the determinants guiding pathway selection in vivo remain unclear. Through comprehensive screening, we identified 18 mutations in the HIV-1 Env protein that enhance resistance to the FDA-approved small-molecule therapeutic temsavir. We then examined their occurrence in HIV-infected individuals who developed resistance on therapy. Only a subset of the resistance-enhancing mutations emerged in vivo. On-treatment mutation frequencies correlated with their spontaneous emergence rates in temsavir-untreated individuals, and were governed by two parameters: (i) Probability of mutation appearance, determined by number and type of nucleotide changes required, and (ii) Probability of mutation persistence, determined by Env functional and immune fitness. Notably, non-neutralizing antibodies commonly-elicited in HIV-infected individuals restricted emergence of multiple resistant forms, driving convergence to a narrow set of escape routes. These findings establish a quantitative framework for predicting therapeutic resistance and reveal how host-immunity constrains viral evolution during treatment.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Gillman, A. N., Birler, C. M., Vujjini, R. R., Fili, M., McCarthy-Potter, S. A., Chen, W., Broghammer, M. M., Hu, G., Gartland, M. J., Prakash, M., Helverson, A., Brown, G. D., Haim, H.. 2025-12-27. Comprehensive Mapping of the Virus and Host Factors that Guide the Paths of HIV-1 Escape from a Therapeutic. https://doi.org/10.64898/2025.12.27.696684
Cite the original work for its findings. Save a collection to share your selection of sources.